Doxazosin Tablet
Product Images NDC 66267-377

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 66267-377). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

66267 377 30

The label for Doxazosin 4 mg tablets from NuCare Pharmaceuticals, Inc. It indicates a package count of 30 tablets. The label states each tablet contains Doxazosin Mesylate USP equivalent to 4 mg Doxazosin. Tablets are described as round, cream to yellow, scored, with a debossed "C4" on the unscored side. The label includes NDC 66267-377-30 and storage instructions to keep the product at controlled temperature 59-86°F. It carries a warning to keep out of reach of children and specifies Rx Only.*

FDA Label Image

Table 1 (Doxazosin Fig1)

Table summarizing effectiveness data from placebo-controlled trials of doxazosin, showing mean baseline and change values in symptom score and maximum flow rate for study groups, including placebo and 4 mg dosing. The table also includes a bar chart illustrating symptom score and maximum flow rate changes in Study 2 for placebo, 4 mg, and 8 mg doses.*

FDA Label Image

Figure 1 – Study 1 (Doxazosin Fig2)

Two line graphs showing clinical study results for Doxazosin. The left graph plots mean change in total symptom score from baseline over 14 weeks of treatment comparing Doxazosin and placebo groups. The right graph shows mean increase in maximum urinary flow rate (mL/sec) over the same period. Both graphs indicate data points with statistical significance noted in the legend.*

FDA Label Image

Chemical Structure (Doxazosin Str)

Chemical structure of the active ingredient Doxazosin, shown as a complex molecular diagram with a benzodioxane ring, quinazoline nucleus, and several functional groups including methoxy and amine substituents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.